Search results
Pfizer RSV vaccine lags GSK’s as head-to-head competition underway
Reuters via Yahoo Finance· 7 months agoPfizer, which dominated COVID vaccine sales, now finds itself looking up at GSK, whose rival new...
Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 3 months agoIt has been about a month since the last earnings report for GSK (GSK). Shares have added about 3.1%...
Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for GSK (GSK). Shares have added about 6.7% in...
Why It Took So Long to Finally Get an RSV Vaccine
Time via Yahoo News· 1 year agoCredit - Getty Images; GSK Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has...
Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market
Investor's Business Daily· 1 year agoModerna stock rose Wednesday after the biotech said its experimental RSV vaccine proved nearly 84%...
Vaccines for flu and RSV now available ahead of fall virus season
CNN via Yahoo News· 10 months agoWith the fall respiratory virus season just around the corner, major US pharmacy chains have begun...
Helsinki court orders payments to narcolepsy patients in Pandemrix case
Reuters via Yahoo News· 1 year agoHELSINKI (Reuters) -A Helsinki court ordered on Thursday payment of indemnities to a new group of...
J&J bows out of RSV vaccine race after scrapping trial
Reuters via Yahoo News· 1 year agoJ&J made the decision in order "to focus on medicines with the greatest potential benefit to...
Sanofi, GSK score late win with EU COVID booster approval
Reuters via Yahoo News· 2 years ago(Reuters) -Sanofi said on Thursday it won European Union approval for its COVID-19 vaccine booster,...
GSK to Sell Remaining $1.6 Billion Stake in Haleon
Bloomberg via Yahoo Finance· 4 weeks ago(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the...